{"registerEntryDetail":{"account":{"firstPublicationDate":"2022-02-24T15:46:51.000Z","registerNumber":"R001371"},"activity":{"code":"ACT_ORGANIZATION","de":"Unternehmen","en":"Company"},"activityDescription":"Takeda ist ein global führendes, wertebasiertes, forschendes, biopharmazeutisches Unternehmen mit Hauptsitz in Japan. Wir haben uns der Erforschung und Bereitstellung lebensverändernder Therapien verschrieben. Dabei werden wir von unserer Verpflichtung gegenüber Patienten, unseren Mitarbeitenden und der Umwelt geleitet. Takeda fokussiert seine Forschung auf vier Therapiegebiete: Onkologie, Seltene Genetische Erkrankungen & Hämatologie sowie Neurowissenschaften und Gastroenterologie. Außerdem investiert Takeda zielgerichtet in Forschungsaktivitäten in den Bereichen Plasmabasierte Therapien und Impfstoffe. Takeda in Deutschland gehört mit rund 2.300 Mitarbeiterinnen und Mitarbeitern zu den weltweit größten Landesgesellschaften von Takeda. www.takeda.com  \r\n\r\nTakeda begleitet legislative und politische Initiativen und steht als kompetenter Dialogpartner zur Verfügung.","activityOperationType":"SELF_OPERATED","clientOrganizations":[],"clientPersons":[],"codexViolation":false,"donationInformationRequired":false,"donators":[],"employeeCount":{"from":1,"to":10},"fieldsOfInterest":[{"code":"FOI_BUNDESTAG","de":"Bundestag","en":"Bundestag"},{"code":"FOI_BUNDESTAG|FOI_BUNDESTAG_PARLIAMENTARY","de":"Parlamentarisches Verfahren","en":"Parliamentary procedure"},{"code":"FOI_DEVELOPMENT_POLICY","de":"Entwicklungspolitik","en":"Development policy"},{"code":"FOI_ECONOMY","de":"Wirtschaft","en":"Economy"},{"code":"FOI_ECONOMY|FOI_ECONOMY_COMPETITION_LAW","de":"Wettbewerbsrecht","en":"Competition law"},{"code":"FOI_ECONOMY|FOI_ECONOMY_INDUSTRIAL","de":"Industriepolitik","en":"Industrial policy"},{"code":"FOI_ENERGY","de":"Energie","en":"Energy"},{"code":"FOI_ENERGY|FOI_ENERGY_OVERALL","de":"Allgemeine Energiepolitik","en":"Energy policy in general"},{"code":"FOI_ENVIRONMENT","de":"Umwelt","en":"Environment"},{"code":"FOI_ENVIRONMENT|FOI_ENVIRONMENT_CLIMATE","de":"Klimaschutz","en":"Climate protection"},{"code":"FOI_ENVIRONMENT|FOI_ENVIRONMENT_OTHER","de":"Sonstiges im Bereich „Umwelt“","en":"Other in the field of “Environment”"},{"code":"FOI_ENVIRONMENT|FOI_ENVIRONMENT_POLLUTION","de":"Immissionsschutz","en":"Immission control"},{"code":"FOI_ENVIRONMENT|FOI_ENVIRONMENT_SUSTAINABILITY","de":"Nachhaltigkeit und Ressourcenschutz","en":"Sustainability and resource protection"},{"code":"FOI_EUROPEAN_UNION|FOI_EU_DOMESTIC_MARKET","de":"EU-Binnenmarkt","en":"EU internal market"},{"code":"FOI_EUROPEAN_UNION|FOI_EU_LAWS","de":"EU-Gesetzgebung","en":"EU legislation"},{"code":"FOI_EUROPEAN_UNION|FOI_EU_POLITICS","de":"Institutionelle Fragen der EU","en":"Institutional questions of European politics"},{"code":"FOI_EUROPEAN_UNION","de":"Europapolitik und Europäische Union","en":"European politics and the EU"},{"code":"FOI_FOREIGN_TRADE","de":"Außenwirtschaft","en":"Foreign trade"},{"code":"FOI_HEALTH","de":"Gesundheit","en":"Health"},{"code":"FOI_HEALTH|FOI_HEALTH_MEDICINE","de":"Arzneimittel","en":"Medicine"},{"code":"FOI_HEALTH|FOI_HEALTH_OTHER","de":"Sonstiges im Bereich „Gesundheit“","en":"Other in the field of “Health”"},{"code":"FOI_HEALTH|FOI_HEALTH_PROMOTION","de":"Gesundheitsförderung","en":"Health promotion"},{"code":"FOI_HEALTH|FOI_HEALTH_SUPPLY","de":"Gesundheitsversorgung","en":"Health supply"},{"code":"FOI_MEDIA","de":"Medien, Kommunikation und Informationstechnik","en":"Media, communication and information technology"},{"code":"FOI_MEDIA|FOI_MEDIA_ADVERTISEMENT","de":"Werbung","en":"Advertising"},{"code":"FOI_MEDIA|FOI_MEDIA_DIGITALIZATION","de":"Digitalisierung","en":"Digitalization"},{"code":"FOI_MEDIA|FOI_MEDIA_PRIVACY","de":"Datenschutz und Informationssicherheit","en":"Data protection and information security"},{"code":"FOI_PUBLIC_FINANCE","de":"Öffentliche Finanzen, Steuern und Abgaben","en":"Public finances, taxes and duties"},{"code":"FOI_SCIENCE_RESEARCH_TECHNOLOGY","de":"Wissenschaft, Forschung und Technologie","en":"Science, research and technology"},{"code":"FOI_SOCIAL_POLICY","de":"Gesellschaftspolitik und soziale Gruppen","en":"Social politics and social groups"},{"code":"FOI_SOCIAL_SECURITY","de":"Soziale Sicherung","en":"Social security"},{"code":"FOI_SOCIAL_POLICY|FOI_SP_DIVERSITY","de":"Diversitätspolitik","en":"Diversity policy"},{"code":"FOI_SOCIAL_POLICY|FOI_SP_GENDER","de":"Geschlechterpolitik","en":"Gender politics"},{"code":"FOI_SOCIAL_SECURITY|FOI_SS_ACCIDENT","de":"Unfallversicherung","en":"Accident insurance"},{"code":"FOI_SOCIAL_SECURITY|FOI_SS_HEALTH","de":"Krankenversicherung","en":"Health insurance"},{"code":"FOI_SOCIAL_SECURITY|FOI_SS_LONGTERM","de":"Pflegeversicherung","en":"Long term care"},{"code":"FOI_WORK","de":"Arbeit und Beschäftigung","en":"Work and employment"},{"code":"FOI_WORK|FOI_WORK_OTHER","de":"Sonstiges im Bereich „Arbeit und Beschäftigung“","en":"Other in the field of “Work and employment”"},{"code":"FOI_WORK|FOI_WORK_POLICY","de":"Arbeitsmarkt","en":"Job market"},{"code":"FOI_WORK|FOI_WORK_RIGHT","de":"Arbeitsrecht/Arbeitsbedingungen","en":"Work right"}],"financialExpensesEuro":{"fiscalYearEnd":"03/21","fiscalYearStart":"04/20","from":720001,"to":730000},"id":5582,"legislativeProjects":[],"lobbyistIdentity":{"address":{"city":"Berlin","country":{"code":"DE"},"type":"NATIONAL"},"identity":"ORGANIZATION","legalForm":{"code":"LF_OTHER_LA","code_de":"Sonstige Personengesellschaft","code_en":"Other legal association","type":"LEGAL_ASSOCIATION"},"legalRepresentatives":[{"commonFirstName":"Heidrun","function":"Geschäftsführerin","lastName":"Irschik-Hadjieff","organizationMemberEmails":["lobbyregister.germany@takeda.com"],"phoneNumber":"+498002953333"},{"commonFirstName":"Jörg","function":"Geschäftsführer","lastName":"Fahlbusch","organizationMemberEmails":["lobbyregister.germany@takeda.com"],"phoneNumber":"+498002953333"}],"membershipEntries":["Verband Forschender Arzneimittelhersteller e.V. (vfa)","Plasma Protein Therapeutics Association (PPTA) Deutschland e.V. ","Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V. (FSA)","Bundesverband Managed Care e.V. (BMC)","Verband der Chemischen Industrie e.V. (VCI)","Vision Zero e.V.","Arbeitsgemeinschaft Therapie Seltene Erkrankungen (ATSE)"],"name":"Takeda Pharma Vertrieb GmbH & Co. KG","namedEmployees":[{"commonFirstName":"Stephanie","lastName":"Schultz"},{"commonFirstName":"Noel","lastName":"Minnis"},{"commonFirstName":"Stefanie","lastName":"Zimmermann"},{"commonFirstName":"Kerstin","lastName":"Angler"},{"commonFirstName":"Sun Kyung","lastName":"Gang"}],"organizationEmails":["lobbyregister.germany@takeda.com"],"phoneNumber":"+498002953333","websites":["www.takeda.de"]},"refuseDonationInformation":false,"refuseFinancialExpensesInformation":false,"refusePublicAllowanceInformation":false,"registerEntryMedia":[{"media":{"fileName":"CoC-Digital-Booklet-External-DE-DE.pdf","mimeType":"application/pdf","url":"https://www.lobbyregister.bundestag.de/media/c0/b6/16452/CoC-Digital-Booklet-External-DE-DE.pdf"},"type":"CODE_OF_CONDUCT"},{"media":{"fileName":"CoC-Digital-Booklet-External-DE-DE.pdf","mimeType":"application/pdf","url":"https://www.lobbyregister.bundestag.de/media/ab/96/16453/CoC-Digital-Booklet-External-DE-DE.pdf"},"type":"CODE_OF_CONDUCT"}]},"registerNumber":"R001371","searchUrl":"https://www.lobbyregister.bundestag.de/suche/R001371/5582","source":"Deutscher Bundestag, Lobbyregister für die Interessenvertretung gegenüber dem Deutschen Bundestag und der Bundesregierung","sourceUrl":"https://www.lobbyregister.bundestag.de"}